Atopic dermatitis treatment: A comprehensive review of conventional and novel bioengineered approaches

Atopic dermatitis (AD) remains a challenging condition, with conventional treatments often leading to adverse effects and limited efficacy. This review explores the diverse landscape of AD treatments, encompassing conventional methods, novel topical and systemic therapies, and emerging bioengineered strategies. While conventional drug administration often requires high dosages or frequent administration, leading to adverse effects, targeted biologics have shown promise. Phototherapy and wet wrap therapy, while helpful, have limitations. Given these factors, the need for modern and effective therapeutic strategies for AD is pressing. Complementary or alternative therapies have garnered significant attention in recent years as a compelling treatment for AD. Among these, functionalized biomaterials and textiles with physicochemical, nanotechnology-based characteristics, or bioengineered features are some of the most common typical adjuvant therapies. The multifunctional-engineered biomaterials, as a new generation of biomedical materials, and stem cells, seem to hold tremendous promise for the treatment of dermatological diseases like AD. Biomaterials have seen great success, especially in various medical fields, due to their unique and adaptable characteristics. These materials, including collagen, PCL, and PLGA, offer unique advantages, such as biocompatibility, biodegradability, controlled drug release, and enhanced drug retention.

Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis

Atopic dermatitis (AD) is a predominant and deteriorating chronic inflammation of the skin, categorized by a burning sensation and eczematous lesions in diverse portions of the body. The treatment of AD is exclusively focused to limit the itching, reduce inflammation, and repair the breached barrier of the skin. Several therapeutic agents for the treatment and management of AD have been reported and are in use in clinics. However, the topical treatment of AD has been an unswerving challenge for the medical fraternity owing to the impaired skin barrier function in this chronic skin condition. To surmount the problems of conventional drug delivery systems, numerous nanotechnology-based formulations are emerging as alternative new modalities for AD. Latter enhances the bioavailability and delivery to the target disease site, improves drug permeation and therapeutic efficacy with reduced systemic and off-target side effects, and thus improves patient health and promotes compliance. This review aims to describe the various pathophysiological events involved in the occurrence of AD, current challenges in treatment, evidence of molecular markers of AD and its management, combinatorial treatment options, and the intervention of nanotechnology-based formulations for AD therapeutics.

Full biodegradable elastomeric nanocomposites fabricated by chitin nanocrystal and poly(caprolactone-diol citrate) elastomer

Chitin nanocrystal is a biocompatible and biodegradable nanofiller, with great potential in enhancing the mechanical and biological properties of polymers. Poly(caprolactone-diol citrate) is a kind of citrate-based biodegradable elastomer prepared by an additive-free melt polycondensation of polycaprolactone-diol and citric acid coupled with subsequent thermocuring. Here, a facile casting/evaporation method was utilized to prepare full biodegradable poly(caprolactone-diol citrate)/chitin nanocrystal nanocomposites, and their structure and properties were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, uniaxial tensile test, dynamic mechanical analysis, surface wettability and swelling analysis, thermogravimetric analysis, in vitro degradation, and cytocompatibility test. The results showed the chitin nanocrystals were uniformly distributed in the poly(caprolactone-diol citrate) matrix; with increasing chitin nanocrystal loading, the tensile modulus and strength significantly increased; furthermore, the incorporation of chitin nanocrystals endowed the poly(caprolactone-diol citrate) with more hydrophilicity, lower swelling in phosphate buffered saline solution, slow degradation rate, and greatly improved cytocompatibility. Thus, the chitin nanocrystal was a good bio-based nanofiller that could be used to tune the properties of poly(caprolactone-diol citrate) degradable bioelastomer.

Role of Ceramides in Drug Delivery

Ceramides belong to the sphingolipid group of lipids, which serve as both intracellular and intercellular messengers and as regulatory molecules that play essential roles in signal transduction, inflammation, angiogenesis, and metabolic disorders such as diabetes, neurodegenerative diseases, and cancer cell degeneration. Ceramides also play an important structural role in cell membranes by increasing their rigidity, creating micro-domains (rafts and caveolae), and altering membrane permeability; all these events are involved in the cell signaling. Ceramides constitute approximately half of the lipid composition in the human skin contributing to barrier function as well as epidermal signaling as they affect both proliferation and apoptosis of keratinocytes. Incorporation of ceramides in topical preparations as functional lipids appears to alter skin barrier functions. Ceramides also appear to enhance the bioavailability of drugs by acting as lipid delivery systems. They appear to regulate the ocular inflammation signaling, and external ceramides have shown relief in the anterior and posterior eye disorders. Ceramides play a structural role in liposome formulations and enhance the cellular uptake of amphiphilic drugs, such as chemotherapies. This review presents an overview of the various biological functions of ceramides, and their utility in topical, oral, ocular, and chemotherapeutic drug delivery.